Results 71 to 80 of about 48,129 (210)

Emerging and future therapies for hemophilia

, 2015
Marcus E Carr,1,2 Bartholomew J Tortella3,4 1Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, 2Worldwide Research and Development, Pfizer, Inc., Cambridge, MA, 3Drexel University College of Medicine, Philadelphia, PA, 4Global ...
Carr ME, Tortella BJ
core  

Diagnosis of hemophilia in newborn circumcision: A case presentation

, 2019
Circumcision is often the earliest surgery performed in a young male's life. Though complications in this procedure are rare, prolong postoperative bleeding may be the first sign of undiagnosed hemophilia.
John P. Gearhart, Wesley W. Ludwig, Jason E. Michaud, James L. Liu   +3 more
core   +1 more source

Strengthening hemophilia registries globally: Strategies to improve patient outcomes

Iraqi Journal of Hematology
Hemophilia is a genetic bleeding disorder characterized by a deficiency of clotting factor VIII or IX. Hemophilia registries are structured databases that maintain longitudinal data on people diagnosed with hemophilia. Hemophilia registries maintained at
Saurabh RamBihariLal Shrivastava, Prateek Sudhakar Bobhate, Shweta Sonkusale, Neha Jaiswal   +3 more
doaj   +1 more source

Acquired hemophilia A

Hematology, 2006
Acquired hemophilia A is a rare but severe autoimmune bleeding disorder, resulting from the presence of autoantibodies directed against clotting factor VIII. The etiology of the disorder remains obscure, although approximately half of all cases are associated with other underlying conditions.
openaire   +2 more sources

Hemophilia, cancer and cardiovascular disease.

, 2010
Hemophilia, cancer and cardiovascular ...
Favaloro EJ, LIPPI, Giuseppe, Franchini M, Giuseppe Lippi, Massimo Franchini, Emmanuel J Favaloro   +5 more
core   +1 more source

Haemophilia B: an illustrative review of current challenges and opportunities

Research and Practice in Thrombosis and Haemostasis
Background: Hemophilia B is a genetic bleeding disorder caused by a deficiency of clotting factor IX, which presents unique challenges in clinical management.
Cedric Hermans, Jan Astermark, Sonata Šaulytė Trakymienė, Víctor Jiménez-Yuste   +3 more
doaj   +1 more source

New developments in the management of moderate-to-severe hemophilia B

, 2016
Moniba Nazeef,1,2 John P Sheehan1,2 1Department of Medicine, Division of Hematology/Oncology, 2UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Abstract: Hemophilia B is an X-linked genetic ...
Nazeef M, Sheehan JP
core  

Hemophilia throughout the life cycle

, 2023
Hemophilia is an inherited X-linked coagulopathy defined by a deficiency or abnormality in the clotting function of factor VIII (hemophilia A) or factor IX (hemophilia B).
Catelli, Dayenne Helena, Plentz Portich , Julia, Sekine, Leo, Mariano da Rocha Silla , Lucia, Rasia Bosi , Guilherme, Tabares Calvache, Ebellins, Sander Hoffmann , Daniel, Seganfredo Weber , Cristiane   +7 more
core  

Hostile Hemophilia

, 2010
40-45Adequate government support coupled with public awareness is crucial to tackle the myriad concerns about hemophilia. BLOOD — the river of life — flows through a network of channels spread all over the human body called blood vessels, which bring ...
Chawla, P. Cheena
core  

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia

Patient Preference and Adherence, 2015
Roberto Furlan,1 Sangeeta Krishnan,2 Jeffrey Vietri3 1Advanced Methods, Kantar Health, Epsom, Surrey, UK; 2Global Health Economics and Outcomes Research, Biogen, MA, USA; 3Health Outcomes, Kantar Health, Milan, Italy Introduction: New longer-acting ...
Furlan R, Krishnan S, Vietri J
doaj